MYOF and cancer: Zhang et al13 found that WJ460 directly targets myoferlin, interacts with myoferlin C2 domain and hampers the proper function of myoferlin.13 WJ460 represents a potentially effective therapeutic molecule for preventing myoferlin‐related cancers and provides an opportunity for developing myoferlin‐targeted agents.